Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1.54x is 45% above its 5-year average of -2.78x, near the high end of its 5-year range (-5.98x–-0.54x).
51.32% below its 12-month average of -1.02x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -0.61x.
INTEREST COVERAGE RATIO
-1.54x
INTEREST COVERAGE RATIO AVG TTM
-1.02x
INTEREST COVERAGE RATIO AVG 3Y
-2.46x
INTEREST COVERAGE RATIO AVG 5Y
-2.78x
INTEREST COVERAGE RATIO AVG 10Y
-2.90x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-51.32%
CURRENT VS 3Y AVG
+37.47%
CURRENT VS 5Y AVG
+44.64%
CURRENT VS 10Y AVG
+46.94%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+75.84%
vs the sector median at left
Establishment Labs Holdings Inc.
Market Cap
$1.92B
Interest Coverage Ratio
-1.54x
TTM Avg
-1.02x
3Y Avg
-2.46x
5Y Avg
-2.78x
Market Cap
$1.94B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.90B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.96B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.96B
Interest Coverage Ratio
-1.02x
TTM Avg
0.38x
3Y Avg
0.38x
5Y Avg
0.21x
Market Cap
$1.89B
Interest Coverage Ratio
-0.40x
TTM Avg
732.40x
3Y Avg
732.40x
5Y Avg
732.40x
Market Cap
$1.88B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.87B
Interest Coverage Ratio
-6.63x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Establishment Labs Holdings Inc. (ESTA) | $1.92B | -1.54x | -1.02x | -2.46x | -2.78x |
| Zymeworks Inc. (ZYME)vs › | $1.91B | N/A | N/A | N/A | N/A |
| Vir Biotechnology, Inc. (VIR)vs › | $1.94B | N/A | N/A | N/A | N/A |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.90B | N/A | N/A | N/A | N/A |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.96B | N/A | N/A | N/A | N/A |
| AxoGen, Inc. (AXGN)vs › | $1.96B | -1.02x | 0.38x | 0.38x | 0.21x |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | -0.40x | 732.40x | 732.40x | 732.40x |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.88B | N/A | N/A | N/A | N/A |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.87B | -6.63x | N/A | N/A | N/A |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.98B | 371.93x | 1006.04x | 1006.04x | 1006.04x |
Interest Coverage
-1.5x
Debt/Equity
12.20
Current Ratio
3.84
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -0.61x |
| 2026-03-31 | -0.92x |
| 2025-12-31 | -0.54x |
| 2025-09-30 | -0.65x |
| 2025-06-30 | -2.37x |
| 2025-03-31 | -2.90x |
| 2024-12-31 | -3.14x |
| 2024-09-30 | -2.47x |
| 2024-06-30 | -1.80x |
| 2024-03-31 | -2.02x |
| 2023-12-31 | -5.10x |
| 2023-09-30 | -5.72x |
| 2023-06-30 | -3.79x |
| 2023-03-31 | -2.17x |
| 2022-12-31 | -5.98x |
| 2022-09-30 | -2.71x |
| 2022-06-30 | -3.07x |
| 2022-03-31 | -2.43x |
| 2021-12-31 | -4.03x |
| 2021-09-30 | -3.94x |
| 2021-06-30 | -2.06x |
| 2021-03-31 | -0.95x |
| 2020-12-31 | -3.63x |
| 2020-09-30 | -0.90x |
| 2020-06-30 | -4.51x |
| 2020-03-31 | -3.59x |
| 2019-12-31 | -2.07x |
| 2019-09-30 | -4.86x |
| 2019-06-30 | -3.72x |
| 2019-03-31 | -3.74x |
| 2018-12-31 | -3.80x |
| 2018-09-30 | -2.74x |
| 2018-06-30 | -2.91x |
| 2018-03-31 | -1.33x |
| 2017-12-31 | -2.57x |
| 2017-09-30 | -0.89x |
| 2017-06-30 | -5.41x |
| 2017-03-31 | -4.25x |
